Why the government must urgently raise the NICE cost-effectiveness threshold
In this piece, Victoria Jordan, ABPI's Director, Value and Access Policy, explains why the government must increase NICE’s baseline threshold to ensure that NHS patients benefit from timely access to…
Read the full articleYou might also wanna read
iRacing Subscription Price Increase (August 2026): How to Lock in Current Rates
BoxThisLap·17h ago
New York Fed Finds Tariff-Driven Price Hikes Will Stretch Past 2026
PYMNTS·2d ago
Understanding NHS medicines spending in England
ABPI·2d ago
New ORA 5 SUV lands in SA with petrol, hybrid, and EV models from R365k
htxt.co.za·2d ago
Updates to the NHS Commercial Framework must deliver more flexibility to support timely access to medicines
ABPI·3d ago
GLM 5.2 and the AI Margin Collapse Thesis
developersdigest.tech·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.